Jens Holstein
Director of Finance/CFO presso BIONTECH SE
Patrimonio netto: 734 580 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Jens Holstein
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
42
| Public Company | Biotechnology | 42 |
| Public Company | Medical Specialties | 30 | |
15
| Public Company | Biotechnology | 15 |
| Public Company | Biotechnology | 5 | |
Wittgensteiner Kliniken AG
2
| Extinct | Hospital/Nursing Management | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jens Holstein tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Public Communications Contact | |
| FRESENIUS SE & CO. KGAA | Medical Specialties | Chief Executive Officer Director of Finance/CFO | |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director of Finance/CFO Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ILLUMINA, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Investor Relations Contact Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| Ci3 Management UG | Chairman Founder Director/Board Member | ||
| IQVIA HOLDINGS INC. | Services to the Health Industry | Chief Operating Officer Director/Board Member General Counsel | |
| University of Maryland | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| University of San Diego | College/University | Undergraduate Degree Director/Board Member Masters Business Admin | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree | |
| 4SC AG | Biotechnology | Investor Relations Contact Director/Board Member Director/Board Member | |
| MEDIGENE AG | Biotechnology | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Public Communications Contact Human Resources Officer General Counsel | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Indiana University | College/University | Undergraduate Degree Undergraduate Degree | |
Sanford Burnham Prebys Medical Discovery Institute
 Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Medical/Nursing Services | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Genoptix, Inc.
 Genoptix, Inc. Medical SpecialtiesHealth Technology Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA. | Medical Specialties | Director/Board Member Founder | |
IQVIA RDS, Inc.
 IQVIA RDS, Inc. Miscellaneous Commercial ServicesCommercial Services IQVIA RDS, Inc. (North Carolina) provides solutions to the healthcare industry. The company was founded by Dennis B. Gillings in 1982 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director of Finance/CFO General Counsel | |
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| MCG CAPITAL CORP | Investment Managers | Director/Board Member Chief Executive Officer | |
Fresenius Medical Care Management AG
 Fresenius Medical Care Management AG Medical DistributorsDistribution Services Part of Fresenius SE & Co. KGaA, Fresenius Medical Care Management AG is a German company that provides innovative products, therapies, and services to create a livable future for their patients. The private company is based in Bad Homburg, Germany. The company specializes in chronic and acute kidney dialysis and therapeutic apheresis. The company was founded in 2005. The CEO is Helen Giza. | Medical Distributors | Director of Finance/CFO Chairman | |
| PROGYNY, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Aicuris Anti-Infective Cures AG
 Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The private company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| Stanford University | College/University | Doctorate Degree Masters Business Admin | |
SHS Gesellschaft für Beteiligungsmanagement mbH
 SHS Gesellschaft für Beteiligungsmanagement mbH Investment ManagersFinance SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) is an independent private equity and venture capital firm founded by Bernhard Schirmers and Reinhilde Spatscheck in 1993, and was headquartered in Tübingen, Baden-Württemberg in the southwest of Germany. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
| MIT Sloan School of Management | College/University | Graduate Degree Masters Business Admin | |
| The College of William & Mary | College/University | Masters Business Admin Undergraduate Degree | |
| EXAGEN INC. | Medical/Nursing Services | Director/Board Member Chairman | |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Corporate Officer/Principal Corporate Officer/Principal | |
| Technische Universität München | College/University | Doctorate Degree Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 30 |
| Germania | 17 |
| Cina | 2 |
| Svizzera | 2 |
Settori
| Health Technology | 20 |
| Consumer Services | 12 |
| Commercial Services | 9 |
| Health Services | 4 |
| Finance | 4 |
Posizioni
| Director/Board Member | 337 |
| Corporate Officer/Principal | 196 |
| Independent Dir/Board Member | 103 |
| Chief Executive Officer | 94 |
| Chairman | 89 |
Contatti più connessi
| Insiders | |
|---|---|
| Fred Cohen | 58 |
| Helmut Jeggle | 47 |
| George Golumbeski | 36 |
| Daniel Camus | 31 |
| Gerald Heinz Möller | 29 |
| Tina Nova | 29 |
| Karin Eastham | 29 |
| Ulrich Wandschneider | 25 |
| Wendy Johnson | 23 |
| David Lemus | 22 |
| Frank Morich | 21 |
| Robert Epstein | 20 |
| Evan Jones | 18 |
| Stephan Sturm | 17 |
| Geoffrey Nicholas Vernon | 17 |
- Borsa valori
- Insiders
- Jens Holstein
- Connessioni Società
